|
ZNF346 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.000540E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.14790002134913E-09 |
| Normal-vs-Stage2 |
1.041990E-01 |
| Normal-vs-Stage3 |
4.139600E-01 |
| Normal-vs-Stage4 |
7.883000E-01 |
| Stage1-vs-Stage2 |
4.085900E-02 |
| Stage1-vs-Stage3 |
3.66569999999955E-05 |
| Stage1-vs-Stage4 |
5.72319999999626E-05 |
| Stage2-vs-Stage3 |
3.168600E-01 |
| Stage2-vs-Stage4 |
1.987180E-01 |
| Stage3-vs-Stage4 |
6.681600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.617940E-04 |
| Normal-vs-AfricanAmerican |
5.026300E-02 |
| Normal-vs-Asian |
1.436150E-02 |
| Caucasian-vs-AfricanAmerican |
8.771800E-01 |
| Caucasian-vs-Asian |
5.093800E-01 |
| AfricanAmerican-vs-Asian |
4.848400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.802300E-03 |
| Normal-vs-Female |
1.5220199999999E-05 |
| Male-vs-Female |
3.257600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.150200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.0741999999947E-05 |
| Normal-vs-Age(61-80Yrs) |
3.739100E-03 |
| Normal-vs-Age(81-100Yrs) |
3.782300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.159500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.075000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.681600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.756610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.082000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.960370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.87130000051106E-07 |
| Normal-vs-Grade 2 |
1.81200000004544E-07 |
| Normal-vs-Grade 3 |
1.038510E-03 |
| Normal-vs-Grade 4 |
2.448400E-02 |
| Grade 1-vs-Grade 2 |
1.099200E-01 |
| Grade 1-vs-Grade 3 |
1.050170E-02 |
| Grade 1-vs-Grade 4 |
5.6505000012308E-08 |
| Grade 2-vs-Grade 3 |
4.013700E-02 |
| Grade 2-vs-Grade 4 |
2.57379673129776E-11 |
| Grade 3-vs-Grade 4 |
1.74940000041701E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.25122134875255E-13 |
| Normal-vs-ccB subtype |
2.651000E-01 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.204220E-03 |
| Normal-vs-N1 |
2.584300E-03 |
| N0-vs-N1 |
1.742750E-03 |
|
|
